Testing effectiveness (Phase 2)Ended earlyNCT04853368
What this trial is testing
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis
Who this might be right for
Cystic Fibrosis (CF)
AbbVie 48